Using CMS' procedure price lookup tool, consumers can view the average payment for common procedures in ASCs and hospital outpatient departments.
GI & Endoscopy
Fighting the pandemic & getting ahead of its lasting effects — 3 insights from Dr. J. DeWayne Tooson
J. DeWayne Tooson, MD, president of Tuscaloosa-based GI Associates of West Alabama, shared insights into the lasting effect of the pandemic and what success will look like in 2021.
Automated text message reminders did not increase colonoscopy attendance or bowel preparation quality, according to a study published in Jama Network Online Jan. 25.
Linda Lee, MD, Medical Director of Endoscopy at Boston-based Brigham and Women's Hospital, shared eight things Brigham and Women's Hospital is executing in 2021 to have a successful year.
The gastroenterology ASC market had revenues of $7.21 billion in 2019 and has $10.27 billion in its sights for 2027, according to a January market report from Reports Globe.
Exact Sciences provided the Kentucky Department for Public Health a grant for 1,000 Cologuard kits, the department announced Jan. 20.
A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion, according to a Jan. 21 news release.
Here are the most-read GI articles during the week of Jan. 18-22:
The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21.
Barrett's esophagus patients may be more vulnerable to COVID-19 infection in their upper gastrointestinal tract after eating or drinking food contaminated with the virus, according to a study published Jan. 20 in Gastroenterology.
